The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease

Dan-Ying Zhang,1,* Lin Zhu,2,* Hai-Ning Liu,1,* Yu-Jen Tseng,3 Shu-Qiang Weng,1 Tao-Tao Liu,1 Ling Dong,1 Xi-Zhong Shen1,41Department of Gastroenterology, Zhongshan Hospital of Fudan University, Shanghai 200032, People’s Republic of China; 2Department of Geriatrics, Zhongshan Hospital of F...

Full description

Bibliographic Details
Main Authors: Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, Shen XZ
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Drug Design, Development and Therapy
Subjects:
Non-alcoholic fatty liver disease
farnesoid X receptor
gastrointestinal microbiome
bile acid
metabolic diseases
Online Access:https://www.dovepress.com/the-protective-effect-and-mechanism-of-the-fxr-agonist-obeticholic-aci-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/the-protective-effect-and-mechanism-of-the-fxr-agonist-obeticholic-aci-peer-reviewed-article-DDDT

Similar Items